Morgan Stanley Sab Biotherapeutics Inc Wt Exp Transaction History

Morgan Stanley

$1.35 Trillion
Q3 2024

A detailed history of Morgan Stanley transactions in Sab Biotherapeutics Inc Wt Exp stock. As of the latest transaction made, Morgan Stanley holds 146,439 shares of SABSW stock, worth $11,715. This represents 0.0% of its overall portfolio holdings.

Number of Shares

146,439

Previous 146,439 -0.0%

Holding current value

$11,715

Previous $7,000 28.57%

% of portfolio

0.0%

Previous 0.0%

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Oct 17, 2024	SELL	$0.02 - $0.07 $50 - $175	-2,500 Reduced 1.68%	146,439 $7,000
Q2 2024 Aug 14, 2024	SELL	$0.02 - $0.07 $50 - $175	-2,500 Reduced 1.68%	146,439 $7,000
Q1 2024 Oct 17, 2024	BUY	$0.02 - $0.04 $50 - $100	2,500 Added 1.71%	148,939 $5,000
Q4 2023 Aug 16, 2024	BUY	$0.03 - $0.1 $75 - $250	2,500 Added 1.71%	148,939 $4,000
Q2 2022 Oct 27, 2022	SELL	$0.12 - $0.41 $228 - $781	-1,907 Reduced 1.26%	148,939 $22,000
Q2 2022 Aug 15, 2022	SELL	$0.12 - $0.41 $228 - $781	-1,907 Reduced 1.26%	148,939 $22,000
Q1 2022 Oct 27, 2022	BUY	$0.22 - $1.87 $419 - $3,566	1,907 Added 1.28%	150,846 $72,000
Q1 2022 May 13, 2022	BUY	$0.22 - $1.87 $26,276 - $223,350	119,439 Added 380.29%	150,846 $72,000
Q4 2021 Feb 14, 2022	BUY	$0.95 - $3.0 $29,836 - $94,221	31,407 New	31,407 $56,000

Others Institutions Holding SABSW

# of Institutions

Shares Held

621K

Call Options Held

602K

Put Options Held

View Full List

About SAB BIOTHERAPEUTICS INC WT EXP

Ticker SABSW
Sector Healthcare
Industry Biotechnology

More about SABSW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account